Latest News - Thermo Fisher Scientific
Top Corporates Hub
Thermo Fisher Scientific
[Latest] Global Adeno Associated Virus Vector Manufacturing Market Size/Share Worth USD 9.87 Billion by 2035 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)
03.02.2026 18:00
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Adeno Associated Virus Vector Manufacturing Market size & share revenue was valued at approximately USD 2.84 Billion in 2025 and is expected to reach USD 3.22 Billion in 2026 and is expected to reach around USD 9.87 Billion by 2035, at a CAGR of 13.4% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Ther
Thermo Fisher to close Franklin MA plant; more than 100 jobs affected
03.02.2026 09:46
Thermo Fisher Scientific Inc. said it's closing its Franklin facility, which will lead to more than 100 jobs lost.
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter
02.02.2026 12:16
Feb 2 (Reuters) - Medical equipment maker Revvity handily beat fourth-quarter estimates and forecast 2026 revenue and profit above Wall Street expectations on Monday, betting on continued strength in
Thermo Fisher Scientific Q4 Earnings Call Highlights
30.01.2026 07:08
Thermo Fisher Scientific (NYSE:TMO) said it delivered a “strong year” in 2025, closing with what management described as an excellent fourth quarter marked by stronger-than-expected operational performance and continued share gains. On the company’s fourth-quarter earnings call, Chairman, President
Thermo Fisher (TMO) Q4 2025 Earnings Transcript
29.01.2026 15:07
A copy of the press release of our fourth quarter and full year 2025 earnings is available in the Investors section of our website under the heading financials. Various remarks that we may make about the company's future expectations, plans, and prospects, constitute forward-looking statements within the meaning of applicable securities laws. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those discussed in the company's most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q under the heading Risk Factors.
Thermo Fisher (TMO) Reports Q4 Earnings: What Key Metrics Have to Say
29.01.2026 14:30
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript
29.01.2026 14:12
Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call January 29, 2026 8:30 AM ESTCompany ParticipantsRafael Tejada - Vice President of Investor...
Thermo Fisher's Q4 Earnings & Revenues Top Estimates, Stock Climbs
29.01.2026 13:48
TMO beats Q4 EPS and revenue estimates, posts 7.1% sales growth, and sees shares rise after results despite margin pressure.
Lonza Group Continues To Leverage Biopharma's Optimization Push
29.01.2026 12:17
Lonza Group stock is a top CDMO benefiting from biopharma outsourcing, strong growth, and expanding margins. Learn more about its upside potential.
Thermo Fisher Scientific (TMO) Beats Q4 Earnings and Revenue Estimates
29.01.2026 12:10
Thermo Fisher (TMO) delivered earnings and revenue surprises of +2.13% and +2.28%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher beats fourth-quarter expectations, shares climb
29.01.2026 11:37
Investing.com -- Shares in Thermo Fisher Scientific climbed in premarket trading Thursday after the medical equipment maker reported better-than-expected fourth-quarter results.
Thermo Fisher (NYSE:TMO) Posts Better-Than-Expected Sales In Q4 CY2025
29.01.2026 11:25
Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.2% year on year to $12.22 billion. Its non-GAAP profit of $6.57 per share was 1.9% above analysts’ consensus estimates.
Thermo Fisher: Q4 Earnings Snapshot
29.01.2026 11:15
TMO) on Thursday reported fourth-quarter net income of $1.96 billion. On a per-share basis, the Waltham, Massachusetts-based company said it had net income of $5.21. Earnings, adjusted for one-time gains and costs, came to $6.57 per share.
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results
29.01.2026 11:00
WALTHAM, Mass., January 29, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
Thermo Fisher (TMO) Q4 Earnings: What To Expect
28.01.2026 03:05
Life sciences company Thermo Fisher (NYSE:TMO) will be reporting results this Thursday before market hours. Here’s what investors should know.
Thermo Fisher Scientific (TMO) Valuation Check After Recent Share Price Momentum
28.01.2026 00:21
Thermo Fisher Scientific: recent gains put performance in focus Thermo Fisher Scientific (TMO) has drawn investor attention after a period of steady share price moves, with the stock up around 7% over the past month and 12% in the past 3 months. See our latest analysis for Thermo Fisher Scientific. That recent 7.4% 30 day share price return and 11.8% 90 day share price return, against a 1 year total shareholder return of 7.2%, suggests momentum has been building from a relatively steady...
Countdown to Thermo Fisher (TMO) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
26.01.2026 14:15
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Thermo Fisher (TMO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Comparator Drug Sourcing Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Clinigen, BAP Pharma Group, Thermo Fisher Scientific, Laboratory Corporation of America, Catalent and More
26.01.2026 12:16
Opportunities in the market include the rising demand due to increased clinical trials & biosimilar developments, especially in oncology and immunology. Advanced cold chain logistics and AI-driven demand forecasting also represent growing areas for innovation and investment. Comparator Drug Sourcing Market Comparator Drug Sourcing Market Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Comparator Drug Sourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has
Whole Genome and Exome Sequencing: Global Market Review 2021-2025 and Growth Outlook 2026-2031 Featuring Illumina, Thermo Fisher Scientific, BGI Genomics and Other Leading Players
23.01.2026 14:37
The market for whole genome and exome sequencing is set to grow significantly, driven by decreasing sequencing costs and a shift toward precision medicine. Opportunities lie in enhancing genomic profiling, despite challenges with data management and regulatory issues. Whole Genome and Exome Sequencing Market Whole Genome and Exome Sequencing Market Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forec